Abnormal insulin secretion and glucose metabolism in pancreatic islets from the spontaneously diabetic GK rat
Tóm tắt
Insulin secretion and islet glucose metabolism were compared in pancreatic islets isolated from GK/Wistar (GK) rats with spontaneous Type 2 (non-insulin-dependent) diabetes mellitus and control Wistar rats. Islet insulin content was 24.5±3.1 μU/ng islet DNA in GK rats and 28.8±2.5 μU/ng islet DNA in control rats, with a mean (±SEM) islet DNA content of 17.3±1.7 and 26.5±3.4 ng (p < 0.05), respectively. Basal insulin secretion at 3.3 mmol/l glucose was 0.19±0.03 μ · ng islet DNA−1· h−1 in GK rat islets and 0.40±0.07 in control islets. Glucose (16.7 mmol/l) stimulated insulin release in GK rat islets only two-fold while in control islets five-fold. Glucose utilization at 16.7 mmol/l glucose, as measured by the formation of 3H2O from [5-3 H]glucose, was 2.4 times higher in GK rat islets (3.1±0.7 pmol · ng islet DNA−1 · h−1) than in control islets (1.3±0.1 pmol · ng islet DNA−1 · h−1; p<0.05). In contrast, glucose oxidation, estimated as the production of 14CO2 from [U-14C]glucose, was similar in both types of islets and corresponded to 15±2 and 30±3 % (p<0.001) of total glucose phosphorylated in GK and control islets, respectively. Glucose cycling, i. e. the rate of dephosphorylation of the total amount of glucose phosphorylated, (determined as production of labelled glucose from islets incubated with 3H2O) was 16.4±3.4% in GK rat and 6.4±1.0% in control islets, respectively (p<0.01). We conclude that insulin secretion stimulated by glucose is markedly impaired in GK rat islets. Glucose metabolism is also altered in GK rat islets, with diminished ratio between oxidation and utilization of glucose, and increased glucose cycling, suggesting links between impaired glucose-induced insulin release and abnormal glucose metabolism.
Tài liệu tham khảo
Efendic S, Luft R, Wajngot A (1984) Aspects of the pathogenesis of type 2 diabetes. Endocr Rev 5: 395–410
Efendic S, Berggren P-O, Khan A, Östenson C-G (1991) Aspects of insulin release in NIDDM. In: Rifkin H, Colwell JA, Taylor SI (eds) Diabetes 1991. Elsevier Sci, Amsterdam, pp 169–172
Porte D Jr (1991) ß-cells in type II diabetes mellitus. Diabetes 40: 166–180
Weir GC, Leahy JL, Bonner-Weir S (1986) Experimental reduction of b-cell mass: implications for the pathogenesis of diabetes. Diabetes Metab Rev 2: 125–161
Grill V, Westberg M, Östenson C-G (1987) B-cell insensitivity in a rat model of non-insulin-dependent diabetes. Evidence for a rapidly reversible effect of previous hyperglycemia. J Clin Invest 80: 664–669
Blondel O, Bailbe D, Portha B (1989) Relation of insulin deficiency to impaired insulin action in NIDDM adult rats given streptozotocin as neonates. Diabetes 38: 610–617
Khan A, Chandramouli V, Östenson C-G, Löw H, Landau BR, Efendic S (1990) Glucose cycling in islets from normal and diabetic rats. Diabetes 39: 456–459
Portha B, Giroix M-H, Serradas P et al. (1988) Insulin production and glucose metabolism in isolated pancreatic islets of rats with NIDDM. Diabetes 37: 1226–1233
Grill V, Östenson C-G (1988) The influence of a diabetic state on insulin secretion: studies in animal models of non-insulin dependent diabetes. In: Grill V, Efendic S (eds) Pathogenesis of non-insulin-dependent diabetes mellitus. Raven Press, New York, pp 93–106
Halban PA, Bonner-Weir S, Weir GC (1983) Elevated proinsulin biosynthesis in vitro from a rat model of non-insulin-dependent diabetes mellitus. Diabetes 32: 277–281
Malaisse WJ, Giroix M-H, Zähner D, Marynissen G, Sener A, Portha B (1991) Neonatal streptozotocin injection: a model of glucotoxicity? Metabolism 40: 1101–1105
Kimura K, Toyota T, Kakizaki M, Kudo M, Takebe K, Goto Y (1982) Impaired insulin secretion in the spontaneous diabetirats. Tohoku J Exp Med 137: 453–459
Goto Y, Suzuki K, Sasaki M, Ono T, Abe S (1988) GK rat as a model of nonobese, noninsulin-dependent diabetes. Selective breeding over 35 generations. In: Shafrir E, Renold AR (eds) Frontiers in diabetes research. Lessons from animal diabetes II. John Libbey, London, pp 301–303
Portha B, Serradas P, Bailbe D, Suzuki K, Goto Y, Giroix M-H (1991) β-cell insensitivity to glucose in the GK rat, a spontaneous nonobese model for type II diabetes. Diabetes 40: 486–491
Loubatières AL, Mariani MM, Ribes G, de Malbosc H, Chapal J (1969) Étude expérimentale d'un nouveau sulfamide hypoglycémiant particulièrement actif, le HB419 ou glibenclamide. Diabetologia 5: 1–10
Herbert V, Lau KS, Gottlieb CW, Bleicher SJ (1965) Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25: 1375–1384
Östenson C-G, Grill V (1986) Differences in long-term effects of l-glutamine and d-glucose on insulin release from rat pancreatic islets. Mol Cell Endocrinol 45: 215–221
Hinegardner RT (1971) An improved fluorometric assay for DNA. Anal Biochem 39: 197–201
Ashcroft SJH, Weerasinghe LCC, Bassett JM, Randle PJ (1972) The pentose cycle and insulin release in mouse pancreatic islets. Biochem J 126: 525–532
Malaisse WJ, Hutton JC, Kawazu S, Herchuelz A, Valverde I, Sener A (1979) The stimulus-secretion coupling of glucose-induced insulin release. XXXV. The links between metabolic and cationic events. Diabetologia 16: 331–341
Arkhammar P, Nilsson T, Rorsman P, Berggren P-O (1987) Inhibition of ATP-regulated K+ channels precedes depolarization-induced increase in cytoplasmic free Ca2+ concentration in pancreatic β-cells. J Biol Chem 262: 5448–5454
Hellman B, Berne C, Grapengiesser E, Grill V, Gylfe E, Lund P-E (1990) The cytoplasmic Ca2+ response to glucose as an indicator of impairment of the pancreatic β-cell function. Eur J Clin Invest 20: S10-S17
Malaisse WJ (1991) The anomeric malaise: a manifestation of ß-cell glucotoxicity. Horm Metab Res 23: 307–311
Giroix M-H, Rasschaert J, Bailbe D et al. (1991) Impairment of glycerol phosphate shuttle in islets from rats with diabetes induced by neonatal streptozotocin. Diabetes 40: 227–232